Alnylampharmaceuticals · Sales · Live in: United States
Posted 2026-10-08 · Verified 2026-11-02
Overview We are looking for an experienced Regional Busines s Director (RBDs to support the promotion of AMVUTTRA® (vutrisiran). The U.S. Food and Drug Administration (FDA) recently approved the supplemental New Drug Application (sNDA) for AMVUTTRA® (vutrisiran). The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults. The RBD will be principally responsible for leading and managing a high-performing team of Busines s Account Executives, focusing on disease awareness and product education among healthcare... Read the full ad